| Esophageal Adenocarcinoma studied in …STUDIED_INderived181 of 181show fewer |
|---|
| → studied in | NCT06324357Phase 1/Phase 2 · recruiting Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06203600Phase 2/Phase 3 · recruiting Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07212491enrolling by invitation Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07603375Phase 2 · recruiting Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05965999recruiting Lucid Registry Study · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392892Phase 2/Phase 3 · recruiting Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06005493Phase 1/Phase 2 · recruiting Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05152147Phase 3 · active not recruiting A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04295811NA · active not recruiting Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06687603NA · recruiting Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248452Phase 3 · active not recruiting Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04921904Phase 1/Phase 2 · completed Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06732388Phase 2 · recruiting Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818018Phase 1/Phase 2 · recruiting A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07818070Phase 3 · not yet recruiting A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02521285Phase 2 · active not recruiting Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05753748NA · recruiting Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01142388Phase 2 · active not recruiting Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06266299Phase 1 · recruiting A Study of KK2269 in Adult Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02962063Phase 1/Phase 2 · active not recruiting Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04391049Phase 1 · active not recruiting Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07090499Phase 1 · recruiting A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677490Phase 3 · recruiting mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05945823Phase 2 · active not recruiting Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544589Phase 1 · recruiting A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07182149Phase 1 · recruiting A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07222657Phase 2 · recruiting Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221893NA · recruiting Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04939051Phase 2 · recruiting Obeticholic Acid for Prevention in Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05713838Phase 2 · active not recruiting Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021066Phase 1 · active not recruiting Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04460937Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615013Phase 1 · recruiting NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Cervical Esophagus Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476796Phase 2 · active not recruiting Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04210115Phase 3 · completed Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06585488Phase 1 · terminated A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06824363early Phase 1 · recruiting ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04389632Phase 1 · recruiting A Study of Sigvotatug Vedotin in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05530343NA · recruiting Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276791NA · recruiting EMR Versus ESD for Barrett's Neoplasia · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Barrett Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07206589NA · not yet recruiting Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07660627NA · recruiting Determining Minimal Residual Disease Using ctDNA Deep Sequencing · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04114136Phase 2 · recruiting Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929392Phase 2 · active not recruiting Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07663786active not recruiting Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07309991recruiting Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07284186Phase 1 · recruiting First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01196390Phase 3 · completed Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06071845NA · recruiting Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594548Phase 1 · not yet recruiting Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06251973Phase 2 · active not recruiting A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432295Phase 2 · recruiting Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846346Phase 2 · recruiting Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05480384Phase 2 · active not recruiting Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223424Phase 2 · recruiting Patient Preference for Subcutaneous vs. Intravenous Immune Therapy · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03161522Phase 2 · recruiting Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02606396NA · completed Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05745857Phase 2 · recruiting Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504615active not recruiting Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366819Phase 4 · suspended Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07490340active not recruiting Trans-Oral Sampling as an Alternative Surveillance of Barrett's Esophagus Pilot · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411133Phase 1 · completed Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00587314enrolling by invitation The Effect of Ablation Therapy on Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Early Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04900818Phase 1 · recruiting Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356311Phase 3 · active not recruiting A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430738Phase 2 · active not recruiting Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523374NA · recruiting A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06623396Phase 1 · recruiting A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06560645Phase 1 · terminated A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04290806recruiting Registry Platform Gastric/Esophageal Cancer (SAPHIR) · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03961945NA · recruiting Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03539822Phase 1/Phase 2 · recruiting Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028167Phase 2 · active not recruiting Induction FLOT With CROSS CRT for Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01618643completed Aceto-whitening in the Assessment of Gastrointestinal Neoplasia · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Barrett Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161818Phase 2 · recruiting Total Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric Junction · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059299Phase 1 · recruiting A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549816Phase 1 · completed A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532734recruiting Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05252416Phase 1 · terminated (VELA) Study of BLU-222 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563766Phase 2 · recruiting A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04408105completed Survey Study on Barrett's Esophagus Screening · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05051475NA · completed Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07164690Phase 2 · not yet recruiting Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02872116Phase 3 · completed Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06030180NA · completed CLUE: CLinical Utility Study of EsoGuard · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05067842withdrawn Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05524844completed The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE) · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03429816NA · completed OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06289374recruiting Longitudinal Assessment of Biomarkers After Oesophagogastric Cancer Surgery · condition mapped PROBABILISTIC · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06702384withdrawn Molecular Analysis of Gastric and OEsophageal Cancers STudy · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04499924Phase 2/Phase 3 · completed Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06642506active not recruiting Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03366012NA · terminated Rapid Assessment of Esophageal Adenocarcinoma Risk Test · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03809624Phase 1 · terminated Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04683939Phase 1/Phase 2 · terminated Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01404156Phase 2/Phase 3 · completed Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05177133Phase 2 · recruiting Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04554771Phase 2 · active not recruiting Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381583completed A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04159974Phase 2 · unknown RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02509286Phase 3 · unknown Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03060642completed The Microenvironment in Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03339843Phase 2 · completed Multiorgan Metabolic Imaging Response Assessment of Abemaciclib · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05069766NA · completed Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05591053NA · unknown Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02830594Phase 2 · completed Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02037048Phase 2 · unknown FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03783936Phase 2 · completed Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307956Phase 2 · terminated Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02971956Phase 2 · completed Pembrolizumab in Refractory Advanced Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05954117NA · not yet recruiting Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530437Phase 1/Phase 2 · terminated Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03427346NA · unknown Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc Resection · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Barrett Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247346NA · unknown Early Detection of Cancer Onset Based on Sensing Field Cancerization at the Organ Level in the Alimentary Tract Using an Integrated Stimulated Raman/Scattering Modality for Endoscopic Real-time in Vivo Measurements · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344810Phase 1/Phase 2 · withdrawn C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05690958unknown Public's Intended Uptake and Views on Organization of Esophageal Cancer Screening · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574327recruiting Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03240679NA · terminated Endoscopic Mucosal Resection and Cellular Matrix · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Barrett Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03982173Phase 2 · withdrawn Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04293458NA · completed Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00586872completed Endoscopic Mucosal Resection (EMR) in Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Early Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04642690terminated Nitrates and IL-8 in Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05642338recruiting A Multicenter Prospective Cohort Study Comparing Random Biopsies Versus Wide-Area Transepithelial Brush-Sampling (WATS) for Surveillance of Barrett's Esophagus, the WATS-EURO2 Study · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628441completed Real-time Computer Aided Detection of Barrett's Neoplasia · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Barrett Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02513784NA · completed Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01212822Phase 2 · completed Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04060342Phase 1 · terminated GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05188313Phase 3 · recruiting TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00573131Phase 2 · terminated Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03365791Phase 2 · completed PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04306458NA · recruiting RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial). · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03592407Phase 2 · withdrawn Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008980completed WATS3D for the Detection of Esophageal Dysplasia · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04018872Phase 2 · recruiting Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001360NA · withdrawn Study of FMT Combined With Nivolumab in Gastric Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00591123Phase 2 · completed Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00487695Phase 3 · completed Confocal Endomicroscopy for Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04669951NA · completed Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003487Phase 2 · terminated Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02128243Phase 2 · completed Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04818476unknown Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's Esophagus · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00064259Phase 1/Phase 2 · terminated A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890979NA · completed Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03474341unknown Preoperative Image-guided Identification of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015389completed Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04194463NA · unknown Maintaining Fitness During Neo-adjuvant Chemotherapy for Oesophago-gastric Cancer: a Feasibility Study · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526328completed DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01362127Phase 2 · completed Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia · condition mapped PROBABILISTIC · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03122548Phase 2 · terminated Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03223662Phase 2 · terminated Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234180Phase 2 · terminated Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01561014Phase 1 · completed Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638909Phase 2 · terminated Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392377Phase 2 · terminated Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01612546Phase 2 · completed Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03307941Phase 1/Phase 2 · withdrawn Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01178944Phase 2 · completed Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231399Phase 1/Phase 2 · completed Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02100189NA · completed Esophageal Cytology With FISH in Detecting Esophageal Cancer · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02610764NA · completed Pilot Sudy: Resectable Esophageal Adenocarcinoma and the Relevance of CTC · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02075905completed Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01129206Phase 2 · completed Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00586989completed Endoscopic Tri-Modal Imaging in Patients With Barrett's Esophagus · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Early Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02628665Phase 3 · unknown Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer · condition mapped CURATED_BROADER · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01932580Phase 2 · completed Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01871636NA · completed ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Barrett Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02464930unknown Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02023541Phase 1 · terminated Proton Beam Therapy to Treat Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00909350completed Micro-RNA (miR) Expression in Upper Gastrointestinal Mucosal Tissue · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165490Phase 2 · completed Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077545Phase 2 · completed 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098527Phase 2 · terminated FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045526Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01776346unknown Barrett's Esophagus Patient Registry · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061958Phase 2 · terminated Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01391208Phase 1 · completed Esophageal Protocol for Detection of Neoplasia in the Digestive Tract · condition mapped ONTOLOGY_EXACT · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00165191Phase 2 · completed Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus · condition mapped ALIAS · 181 trials mapped (84 active) | — | — | Esophageal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |